Shizuoka, Japan

Fumi Umehara

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Kyoto University, Kyowa Medex Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumi Umehara. Retrieved from https://idiyas.com/inventor/fumi-umehara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Shiuoka, JP (2018)
  • Shizuoka, JP (2018)

Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fumi Umehara: Innovator in Glycated Hemoglobin Measurement

Introduction

Fumi Umehara is a notable inventor based in Shizuoka, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the measurement of glycated hemoglobin. With a total of 2 patents, her work is instrumental in diagnosing lifestyle-related diseases such as diabetes mellitus.

Latest Patents

Umehara's latest patents include a method for measuring glycated hemoglobin in a sample. This method involves directly oxidizing glycated hemoglobin and measuring a substance produced or consumed by the oxidation. Another patent focuses on a method that utilizes an enzyme for the same purpose. These innovations are crucial for improving diagnostic accuracy in medical settings. Additionally, she has developed a glycated hexapeptide oxidase, which involves a specific amino acid sequence modification to enhance the measurement of glycated hemoglobin.

Career Highlights

Throughout her career, Umehara has worked with prominent organizations such as Kyowa Medex Co., Ltd. and Kyoto University. Her experience in these institutions has allowed her to refine her research and contribute to advancements in medical technology.

Collaborations

Umehara has collaborated with esteemed colleagues, including Noriyuki Ogawa and Takehide Kimura. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Fumi Umehara's contributions to the measurement of glycated hemoglobin represent a significant advancement in medical diagnostics. Her innovative methods and collaborative efforts continue to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…